| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Gorgoulis VG | |
| Tsantoulis PK | |||
| P2860 | cites work | Shared role of the pRB-related p130 and p107 proteins in limb development | Q42633203 |
| P433 | issue | 16 | |
| P304 | page(s) | 2403-2414 | |
| P577 | publication date | 2005-10-05 | |
| P1433 | published in | European Journal of Cancer | Q332260 |
| P1476 | title | Involvement of E2F transcription factor family in cancer | |
| P478 | volume | 41 |
| Q41863779 | A comprehensive modular map of molecular interactions in RB/E2F pathway |
| Q33861035 | ANKRD22 promotes progression of non-small cell lung cancer through transcriptional up-regulation of E2F1. |
| Q34619596 | APC/CCdc20targets E2F1 for degradation in prometaphase |
| Q42139522 | ARF: a versatile DNA damage response ally at the crossroads of development and tumorigenesis. |
| Q36393246 | Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells |
| Q89905085 | Association of PARP1 polymorphisms with response to chemotherapy in patients with high-risk neuroblastoma |
| Q39179169 | Beyond histones - the expanding roles of protein lysine methylation |
| Q36012026 | Biphasic and Stage-Associated Expression of CPEB4 in Hepatocellular Carcinoma |
| Q92195101 | CDK12 controls G1/S progression by regulating RNAPII processivity at core DNA replication genes |
| Q36859304 | Cataloging and organizing p73 interactions in cell cycle arrest and apoptosis |
| Q89499302 | Cdc6 as a novel target in cancer: Oncogenic potential, senescence and subcellular localisation |
| Q35636555 | Cdc6 expression represses E-cadherin transcription and activates adjacent replication origins. |
| Q38329400 | Critical roles of non-histone protein lysine methylation in human tumorigenesis |
| Q39761702 | Dynamic NF-κB and E2F interactions control the priority and timing of inflammatory signalling and cell proliferation. |
| Q37628111 | E2F and GATA switches turn off WD repeat domain 77 expression in differentiating cells |
| Q59803813 | E2F transcription factor 8 promotes cell proliferation via CCND1/p21 in esophageal squamous cell carcinoma |
| Q42772377 | E2F transcription factors and digestive system malignancies: how much do we know? |
| Q36897885 | E2F transcription factors and digestive system malignancies: how much do we know? |
| Q43537069 | E2F-1 is overexpressed and pro-apoptotic in human hepatocellular carcinoma |
| Q44298281 | E2F-1-deficient NOD/SCID mice developed showing decreased saliva production |
| Q97522290 | E2F-dependent transcription determines replication capacity and S phase length |
| Q36040603 | E2F1 and E2F2 prevent replicative stress and subsequent p53-dependent organ involution. |
| Q37246053 | E2F1 expression is deregulated and plays an oncogenic role in sporadic Burkitt's lymphoma |
| Q53168345 | E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells. |
| Q39095899 | E2F1-mediated DNA damage is implicated in 8-Cl-adenosine-induced chromosome missegregation and apoptosis in human lung cancer H1299 cells. |
| Q33776715 | E2F8 is a Potential Therapeutic Target for Hepatocellular Carcinoma |
| Q37686046 | E2F8, a direct target of miR-144, promotes papillary thyroid cancer progression via regulating cell cycle |
| Q55315668 | Expression patterns of E2F transcription factors and their potential prognostic roles in breast cancer. |
| Q39126232 | Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer |
| Q54345062 | Functional p53 can modulate the relationship between E2F-1 expression and tumor kinetics in Hodgkin lymphoma. |
| Q33396559 | Gene expression meta-analysis identifies metastatic pathways and transcription factors in breast cancer |
| Q24309023 | Human TFDP3, a novel DP protein, inhibits DNA binding and transactivation by E2F |
| Q34159639 | Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway in human colon cancer cells |
| Q64883630 | Integrating the DNA damage and protein stress responses during cancer development and treatment. |
| Q39515741 | JAZ mediates G1 cell cycle arrest by interacting with and inhibiting E2F1 |
| Q42592773 | Knockdown of E2f1 by RNA interference impairs proliferation of rat cells in vitro. |
| Q39660439 | Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1 |
| Q48131428 | Melatonin attenuates dextran sodium sulfate induced colitis with sleep deprivation: possible mechanism by microarray analysis |
| Q39936936 | MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a |
| Q92461222 | MicroRNA-432 Suppresses Invasion and Migration via E2F3 in Nasopharyngeal Carcinoma |
| Q37257213 | Modulation of the E2F1-driven cancer cell fate by the DNA damage response machinery and potential novel E2F1 targets in osteosarcomas |
| Q52651787 | Mutational signatures reveal the role of RAD52 in p53-independent p21-driven genomic instability. |
| Q40101908 | Nuclear expression of E2F4 induces cell death via multiple pathways in normal human intestinal epithelial crypt cells but not in colon cancer cells |
| Q85158671 | Pin1 acts as a modulator of cell proliferation through alteration in NF‐κB but not β‐catenin/TCF4 signalling in a subset of endometrial carcinoma cells |
| Q64228137 | Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma |
| Q36579266 | Rb family proteins as modulators of gene expression and new aspects regarding the interaction with chromatin remodeling enzymes |
| Q50929183 | Regulation of E2F1 by the von Hippel-Lindau tumour suppressor protein predicts survival in renal cell cancer patients. |
| Q41918598 | Ritonavir-Mediated Induction of Apoptosis in Pancreatic Cancer Occurs via the RB/E2F-1 and AKT Pathways |
| Q36764481 | Roles of CREB-binding protein (CBP)/p300 in respiratory epithelium tumorigenesis |
| Q58798661 | Screening Method for Anti-Colon Cancer Drugs Using Two Sensor Cell Lines with Human β4-Galactosyltransferase 4 Gene Promoters |
| Q64061316 | Serve as Potential Prognostic Biomarkers and Targets for Human Ovarian Cancer |
| Q37220014 | The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis |
| Q37118684 | The E2F1 oncogene transcriptionally regulates NELL2 in cancer cells |
| Q34281551 | The RIP140 gene is a transcriptional target of E2F1. |
| Q39159931 | The Role of the Transcriptional Response to DNA Replication Stress. |
| Q36796878 | The aryl hydrocarbon receptor binds to E2F1 and inhibits E2F1-induced apoptosis |
| Q39873154 | The evolutionary history of the E2F and DEL genes in Viridiplantae |
| Q52378683 | The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1. |
| Q36559648 | Transcriptional networks inferred from molecular signatures of breast cancer |
| Q39996337 | Transcriptional regulation of human RANK ligand gene expression by E2F1. |
| Q28249223 | Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells |
Search more.